← All organizations

AMO Pharma Limited

For profitWebsite ↗

Also known as: AMO Pharma | AMO Pharma Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2024

Timeline

2010s

Jun 1, 2015
AMO Pharma Limited— Founded

Drugs by trial phase (1 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

tideglusib

Indications

Studied for

Myotonic Dystrophy

Recent trials (7)

NCT07119775Lead sponsorN/A—
NCT06174220CollaboratorPhase 2Feb 1, 2024
NCT05004129Study directorPhase 2/Phase 3Aug 23, 2021
NCT05004129Lead sponsorPhase 2/Phase 3Aug 23, 2021
NCT03692312Study directorPhase 2/Phase 3Oct 31, 2018
NCT03692312Lead sponsorPhase 2/Phase 3Oct 31, 2018
NCT02858908Lead sponsorPhase 2Aug 4, 2016

Details

Founded: Wonersh, GB Jun 1, 2015
Last known activity: Feb 1, 2024